as 12-24-2024 4:00pm EST
Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.
Founded: | 1985 | Country: | United States |
Employees: | N/A | City: | DUBLIN |
Market Cap: | 22.1B | IPO Year: | 1992 |
Target Price: | $262.50 | AVG Volume (30 days): | 565.1K |
Analyst Decision: | Buy | Number of Analysts: | 5 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 4.37 | EPS Growth: | -20.57 |
52 Week Low/High: | $197.82 - $248.24 | Next Earning Date: | 02-05-2025 |
Revenue: | $5,325,525,000 | Revenue Growth: | 15.75% |
Revenue Growth (this year): | 7.91% | Revenue Growth (next year): | 6.37% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Majors Cary L | STE | SVP and President, Healthcare | Nov 25 '24 | Sell | $217.32 | 1,682 | $365,532.24 | 11,372 |
STE Breaking Stock News: Dive into STE Ticker-Specific Updates for Smart Investing
Argus Research
2 days ago
Simply Wall St.
2 days ago
Argus Research
8 days ago
Zacks
8 days ago
Argus Research
15 days ago
Zacks
19 days ago
Argus Research
22 days ago
Zacks
a month ago
The information presented on this page, "STE STERIS plc (Ireland) - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.